James Fingleton

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial

Jo Hardy, Christina Baggott, James Fingleton et al. · The Lancet · 2019 · 263 citations

Asthma, Pulmonary Care, Allergy +6

Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

John W. Upham, Chantal Le Lievre, David J. Jackson et al. · The Journal of Allergy and Clinical Immunology In Practice · 2021 · 137 citations · Full text

Asthma, Allergy, Allergy Medicine +6

Serum periostin in obstructive airways disease

James Fingleton, Irene Braithwaite, Justin Travers et al. · European Respiratory Journal · 2016 · 54 citations · Full text

Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults

James Fingleton, Justin Travers, Mathew Williams et al. · Journal of Allergy and Clinical Immunology · 2015 · 48 citations · Full text

Asthma, Treatment Responsiveness, Interventional Pulmonology +6

Changes in Microvascular Reactivity After Cardiopulmonary Bypass in Patients With Poorly Controlled Versus Controlled Diabetes

Jun Feng, Yuhong Liu, Louis M. Chu et al. · Circulation · 2012 · 45 citations · Full text